Global Insulin Market Status and Outlook 2018-2025

July 2018 | 207 pages | ID: G8D362E09A3EN
99Strategy

Abstracts

Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies

• Novartis
• Novo Nordisk
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Eli Lilly
• MannKind
• Sanofi
• Merck
• Bioton
• GEA
• Emisphere
• Salix Pharmaceuticals
• Gan & Lee
• Dongbao
• United Laboratories (TUL)
• Takeda Pharmaceutical Company
• Shihuida PHARMA Group
• Henan Tian Fang Pharmaceutical
• Disha Pharmaceutical Group

Market by Type

• Ultra-short-acting insulin
• Short-acting insulin
• In effect insulin
• Long-acting insulin

Market by Application

• Type 1 diabetes
• Type 2 diabetes
• Others diabetes

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Insulin Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Ultra-short-acting insulin
  3.1.2 Short-acting insulin
  3.1.3 In effect insulin
  3.1.4 Long-acting insulin
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Type 1 diabetes
  4.1.2 Type 2 diabetes
  4.1.3 Others diabetes
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Ultra-short-acting insulin Production by Region
    6.1.1.2 Short-acting insulin Production by Region
    6.1.1.3 In effect insulin Production by Region
    6.1.1.4 Long-acting insulin Production by Region
  6.1.2 Production by Application
    6.1.2.1 Type 1 diabetes Production by Region
    6.1.2.2 Type 2 diabetes Production by Region
    6.1.2.3 Others diabetes Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Ultra-short-acting insulin Demand by Region
    6.2.1.2 Short-acting insulin Demand by Region
    6.2.1.3 In effect insulin Demand by Region
    6.2.1.4 Long-acting insulin Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Type 1 diabetes Demand by Region
    6.2.2.2 Type 2 diabetes Demand by Region
    6.2.2.3 Others diabetes Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Novartis
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Novo Nordisk
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Boehringer Ingelheim
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Bristol-Myers Squibb
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Eli Lilly
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 MannKind
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Sanofi
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Merck
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Bioton
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 GEA
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 Emisphere
8.12 Salix Pharmaceuticals
8.13 Gan & Lee
8.14 Dongbao
8.15 United Laboratories (TUL)
8.16 Takeda Pharmaceutical Company
8.17 Shihuida PHARMA Group
8.18 Henan Tian Fang Pharmaceutical
8.19 Disha Pharmaceutical Group

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Insulin Industry Dynamics & Regulations List
Table Global Insulin Sales Revenue, Cost and Margin, 2015-2018E
Table Global Insulin Market Status by Type 2015-2018E, in USD Million
Table Global Insulin Market Status by Application 2015-2018E, in USD Million
Table Global Insulin Market Status by Application 2015-2018E, in Volume
Table Global Insulin Market by Region 2015-2018E, in USD Million
Table Global Insulin Market Share by Region in 2018, in USD Million
Table Global Insulin Market by Region 2015-2018E, in Volume
Table Global Insulin Market Share by Region in 2018, in Volume
Table Ultra-short-acting insulin Production Value by Region 2015-2018E, in USD Million
Table Ultra-short-acting insulin Production Volume by Region 2015-2018E, in Volume
Table Short-acting insulin Production Value by Region 2015-2018E, in USD Million
Table Short-acting insulin Production Volume by Region 2015-2018E, in Volume
Table In effect insulin Production Value by Region 2015-2018E, in USD Million
Table In effect insulin Production Volume by Region 2015-2018E, in Volume
Table Long-acting insulin Production Value by Region 2015-2018E, in USD Million
Table Long-acting insulin Production Volume by Region 2015-2018E, in Volume
Table Type 1 diabetes Production Value by Region 2015-2018E, in USD Million
Table Type 1 diabetes Production Volume by Region 2015-2018E, in Volume
Table Type 2 diabetes Production Value by Region 2015-2018E, in USD Million
Table Type 2 diabetes Production Volume by Region 2015-2018E, in Volume
Table Others diabetes Production Value by Region 2015-2018E, in USD Million
Table Others diabetes Production Volume by Region 2015-2018E, in Volume
Table Ultra-short-acting insulin Market Size by Region 2015-2018E, in USD Million
Table Ultra-short-acting insulin Market Size by Region 2015-2018E, in Volume
Table Short-acting insulin Market Size by Region 2015-2018E, in USD Million
Table Short-acting insulin Market Size by Region 2015-2018E, in Volume
Table In effect insulin Market Size by Region 2015-2018E, in USD Million
Table In effect insulin Market Size by Region 2015-2018E, in Volume
Table Long-acting insulin Market Size by Region 2015-2018E, in USD Million
Table Long-acting insulin Market Size by Region 2015-2018E, in Volume
Table Type 1 diabetes Market Size by Region 2015-2018E, in USD Million
Table Type 1 diabetes Market Size by Region 2015-2018E, in Volume
Table Type 2 diabetes Market Size by Region 2015-2018E, in USD Million
Table Type 2 diabetes Market Size by Region 2015-2018E, in Volume
Table Others diabetes Market Size by Region 2015-2018E, in USD Million
Table Others diabetes Market Size by Region 2015-2018E, in Volume
Table GlobalInsulin Forecast by Type 2019F-2025F, in USD Million
Table Insulin Forecast by Type 2019F-2025F, in Volume
Table Insulin Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Insulin Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Insulin Market Forecast by Region 2019F-2025F, in USD Million
Table Insulin Market Forecast by Region 2019F-2025F, in Volume
Table Novartis Information
Table Insulin Sales, Cost, Margin of Novartis
Table Novo Nordisk Information
Table Insulin Sales, Cost, Margin of Novo Nordisk
Table Boehringer Ingelheim Information
Table Insulin Sales, Cost, Margin of Boehringer Ingelheim
Table Bristol-Myers Squibb Information
Table Insulin Sales, Cost, Margin of Bristol-Myers Squibb
Table Eli Lilly Information
Table Insulin Sales, Cost, Margin of Eli Lilly
Table MannKind Information
Table Insulin Sales, Cost, Margin of MannKind
Table Sanofi Information
Table Insulin Sales, Cost, Margin of Sanofi
Table Merck Information
Table Insulin Sales, Cost, Margin of Merck
Table Bioton Information
Table Insulin Sales, Cost, Margin of Bioton
Table GEA Information
Table Insulin Sales, Cost, Margin of GEA
Table Emisphere Information
Table Insulin Sales, Cost, Margin of Emisphere
Table Salix Pharmaceuticals Information
Table Insulin Sales, Cost, Margin of Salix Pharmaceuticals
Table Gan & Lee Information
Table Insulin Sales, Cost, Margin of Gan & Lee
Table Dongbao Information
Table Insulin Sales, Cost, Margin of Dongbao
Table United Laboratories (TUL) Information
Table Insulin Sales, Cost, Margin of United Laboratories (TUL)
Table Takeda Pharmaceutical Company Information
Table Insulin Sales, Cost, Margin of Takeda Pharmaceutical Company
Table Shihuida PHARMA Group Information
Table Insulin Sales, Cost, Margin of Shihuida PHARMA Group
Table Henan Tian Fang Pharmaceutical Information
Table Insulin Sales, Cost, Margin of Henan Tian Fang Pharmaceutical
Table Disha Pharmaceutical Group Information
Table Insulin Sales, Cost, Margin of Disha Pharmaceutical Group
Table Global Insulin Sales Revenue by Company 2015-2017, in USD Million
Table Global Insulin Sales Volume by Company 2015-2017, in Volume
Table Global Insulin Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Insulin Picture
Figure Insulin Industry Chain Diagram
Figure Global Insulin Sales Revenue 2015-2018E, in USD Million
Figure Global Insulin Sales Volume 2015-2018E, in Volume
Figure Global Insulin Market Status by Type 2015-2018E, in Volume
Figure North America Insulin Market Size and Growth 2015-2018E, in USD Million
Figure North America Insulin Market Size and Growth 2015-2018E, in Volume
Figure Europe Insulin Market Size and Growth 2015-2018E, in USD Million
Figure Europe Insulin Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Insulin Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Insulin Market Size and Growth 2015-2018E, in Volume
Figure South America Insulin Market Size and Growth 2015-2018E, in USD Million
Figure South America Insulin Market Size and Growth 2015-2018E, in Volume
Figure Middle East Insulin Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Insulin Market Size and Growth 2015-2018E, in Volume
Figure Africa Insulin Market Size and Growth 2015-2018E, in USD Million
Figure Africa Insulin Market Size and Growth 2015-2018E, in Volume
Figure Global Insulin Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Insulin Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Insulin Sales Price Forecast 2019F-2025F
Figure Global Insulin Gross Margin Forecast 2019F-2025F
Figure Global Insulin Sales Revenue by Company in 2018, in USD Million
Figure Global Insulin Price by Company in 2018
Figure Global Insulin Gross Margin by Company in 2018